Principal Securities’s Mesoblast MESO Stock Holding History

Principal Securities’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7	Closed	-$113	–	2651
2025 Q3	$113	Buy	+7	New	+$102	﹤0.01%	3688

Other funds holding MESO

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Principal Securities's MESO Position: Q4 2025 in Review

Principal Securities sold out of Mesoblast (MESO) in Q4 2025, closing a stake of 7 shares — an estimated $113 sold.

Principal Securities first reported a position in MESO in Q3 2025 and held it in 1 quarter. The position peaked at $113 in Q3 2025. 74 funds tracked by Wall St. Rank hold MESO as of Q4 2025.

Principal Securities reported no remaining Mesoblast position as of Q4 2025 after selling out during the quarter.
Principal Securities sold 7 Mesoblast shares in Q4 2025, an estimated $113.
Principal Securities first reported a position in Mesoblast in Q3 2025 and held it in 1 quarter.
Principal Securities's Mesoblast position peaked at $113 in Q3 2025.
74 funds tracked by Wall St. Rank held Mesoblast as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.